Skip to main content

Table 1 Baseline demographics and characteristics

From: Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study

Patient characteristics MM patients (n = 7895) Non-MM patients (n = 23,685)
Duration of follow-up, years
 Median (range) 2 (0–9) 2 (0–10)
Age at index date, years
 Mean ± SD 65.3 ± 11.8 65.3 ± 11.8
 Median (range) 64 (18–97) 64 (18–97)
Age, years, n (%)
 18–34 26 (0.3) 78 (0.3)
 35–44 239 (3.0) 717 (3.0)
 45–54 1130 (14.3) 3390 (14.3)
 55–64 2747 (34.8) 8241 (34.8)
 65–74 1812 (23.0) 5436 (23.0)
 75+ 1941 (24.6) 5823 (24.6)
Sex, n (%)
 Male 4400 (55.7) 13,200 (55.7)
 Female 3495 (44.3) 10,485 (44.3)
Year of index date, n (%)
 2005 634 (8.0) 1591 (6.7)
 2006 639 (8.1) 1464 (6.2)
 2007 607 (7.7) 1492 (6.3)
 2008 892 (11.3) 2154 (9.1)
 2009 1136 (14.4) 3193 (13.5)
 2010 832 (10.5) 2445 (10.3)
 2011 1007 (12.8) 3644 (15.4)
 2012 1102 (14.0) 4177 (17.6)
 2013 908 (11.5) 3039 (12.8)
 2014 138 (1.7) 486 (2.1)
Comorbidities at baseline, n (%)
 Hypertension 3002 (38.0) 5750 (24.3)
 Renal failure 1698 (21.5) 696 (2.9)
 Hyperlipidemia 1399 (17.7) 3712 (15.7)
 Diabetes mellitus 1242 (15.7) 3007 (12.7)
 Ischemic heart disease 841 (10.7) 1777 (7.5)
 Cardiac dysrhythmias 563 (7.1) 1019 (4.3)
 Congestive heart failure 526 (6.7) 549 (2.3)
 Cardiomyopathy 168 (2.1) 176 (0.7)
 Amyloidosis 110 (1.4) 3 (0.01)
 Acute myocardial infarction 106 (1.3) 133 (0.6)
 Cerebrovascular diseasea 100 (1.3) 159 (0.7)
 Hypertension + renal failure 1034 (13.1) 494 (2.1)
 Hypertension + congestive heart failure 322 (4.1) 320 (1.4)
 Hypertension + renal failure + congestive heart failure 179 (2.3) 116 (0.5)
CCI
 Mean ± SD 1.44 ± 1.93 0.41 ± 1.01
 Median (range) 1 (0–12) 0 (0–15)
  1. CCI: Charlson comorbidity index, MM: multiple myeloma, SD: standard deviation
  2. aBased on inpatient claim only